-
PROJECT ORBIS AND ONTARIO FAST: ARE THEY CLOSING THE GAP IN ACCESS TO MEDICINES FOR ALL PATIENTS?
Mar 18, 2026, 21:38 PM -
ARE MEDICARE’S NEGOTIATED PRICES FOR APIXABAN AND RIVAROXABAN CONSISTENT WITH VALUE BASED PRICES? EVIDENCE FROM A SYSTEMATIC REVIEW OF U.S. COST-EFFECTIVENESS ANALYSES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF FITUSIRAN PROPHYLAXIS VERSUS FACTOR VIII ON-DEMAND OR PROPHYLACTIC THERAPY FOR HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Mar 18, 2026, 21:38 PM -
COMPARISON OF SAMPLING STRATEGIES TO ADDRESS SEVERE DATA IMBALANCE AND COMPUTATIONAL BENCHMARKING FOR TIME-TO-EVENT PREDICTIVE MODEL DEVELOPMENT ACROSS LOCAL AND HIGH-PERFORMANCE COMPUTING ENVIRONMENTS: PREDICTION OF ALCOHOL USE DISORDER AND OPIOID...
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE METHODOLOGY FOR ECONOMIC EVALUATION OF CLINICAL AI: COST-EFFECTIVENESS OF AN IMAGING ALGORITHM FOR INCIDENTAL DETECTION OF EMPHYSEMA
Mar 18, 2026, 21:38 PM -
AN EXPANDED ANALYSIS OF WHICH FEATURES CONVEY EMPATHY TO PATIENTS IN SCIENTIFIC WRITING
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ENDOMETRIAL CANCER TREATMENT IN THE PUBLIC SETTING IN BRAZIL
Mar 18, 2026, 21:38 PM -
WHEN ADHERENCE ESTIMATES DIFFER: THE IMPACT OF DATA SOURCE AND GAP HANDLING IN REAL-WORLD MEDICATION USE ASSESSMENT
Mar 18, 2026, 21:38 PM -
HEALTH CARE UTILIZATION DIFFERENCES BETWEEN MEDICARE ADVANTAGE AND STANDALONE PART D PLANS IN MEDICARE BENEFICIARIES WITH CANCER
Mar 18, 2026, 21:38 PM -
CONFIDENCE INTERVALS FOR EVENT-BASED NUMBER NEEDED TO TREAT: A PRACTICAL APPROACH FOR HEALTH ECONOMIC EVALUATION OUTPUTS
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF ALPHA BLOCKERS VERSUS ALPHA INHIBITORS USING PATIENT-REPORTED OUTCOMES AMONG ADULT MEN DIAGNOSED WITH BPH IN THE USA USING MEPS DATA (2018-2023)
Mar 18, 2026, 21:38 PM -
TIME USE TRADE-OFFS IN FAMILY CAREGIVING: EVIDENCE FROM THE AMERICAN TIME USE SURVEY
Mar 18, 2026, 21:38 PM -
REAL-WORLD UTILIZATION-INFORMED, ROUTE-STRATIFIED OPTIMIZATION OF IVIG/SCIG SELECTION TO IMPROVE INFUSION-CENTER THROUGHPUT
Mar 18, 2026, 21:38 PM -
COST AND OUTCOMES OF INTEGRATING SEXUAL AND REPRODUCTIVE HEALTH SERVICES INTO HUMANITARIAN HEALTH PROGRAMS IN IDP CAMPS
Mar 18, 2026, 21:38 PM -
A HOLISTIC EVALUATION OF ADVERSE EFFECTS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) IN PROSTATE CANCER: AN ARTIFICIAL INTELLIGENCE ASSISTED TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
DYNAMIC PRICING IN THE CONTEXT OF COST-EFFECTIVENESS MODELING AND WILLINGNESS-TO-PAY THRESHOLDS
Mar 18, 2026, 21:38 PM -
POST-MARKETING SAFETY PROFILE OF ANTIDEPRESSANTS IN 2013 TO 2025
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW ON ECONOMIC EVALUATION OF LOW-DOSE ATROPINE FOR CHILDHOOD MYOPIA CONTROL: EVIDENCE FROM MODEL INSIGHTS
Mar 18, 2026, 21:38 PM -
UPDATED COST-EFFECTIVENESS ANALYSIS OF POLATUZUMAB VEDOTIN COMBINED WITH CHEMOIMMUNOTHERAPY FOR UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN CHINA: EVIDENCE FROM LONG-TERM FOLLOW-UP OF THE POLARIX ASIAN SUBGROUP
Mar 18, 2026, 21:38 PM
